Xiaojun Wu

5PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 05, 2026
PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-enhancer Formation.

Weihao Li, Jianhong Peng, Jiahua He

|Aug 27, 2025
β-elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1.

Jin Lan, Weili Zhang, Kaixuan Zeng

|May 10, 2024
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

De-Shen Wang, Chao Ren, Shan-Shan Li

|Oct 24, 2021
Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer.

Jianhong Peng, Weihao Li, Wenhua Fan

|Sep 10, 2021
A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis.

Yun Wang, Xiuxing Chen, Haocheng Lin

Pageof 1

Frequent Collaborators

2 joint publications

Deshen Wang

2 joint publications

Weihao Li

2 joint publications

Weili Zhang

1 joint publications

Jian Xiao